APLS — APELLIS PHARMACEUTICALS INC

Ownership history in Engineers Gate Manager LP  ·  12 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2024 Q3)
Avg. % of fund
0.02%
First filed
2020 Q4
Last filed
2025 Q3
Quarters held
12
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 66,336 +7,618 +13.0% 0.02% $1.5M $22.63
2025 Q2 ADDED 58,718 +16,546 +39.2% 0.01% $1.0M $17.31
2025 Q1 REDUCED 42,172 -25,453 -37.6% 0.02% $922K $21.87
2024 Q3 ADDED 67,625 +55,456 +455.7% 0.04% $2.0M $28.84
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APLS price (monthly, adj. close)

Other funds also holding APLS

As of 2025 Q4 — sorted by position size

Deep Track Capital, LP 3Y 3.47% Avoro Capital Advisors LLC 3Y 7Y 3.02% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.13% Siren, L.L.C. 1.93% RTW INVESTMENTS, LP 3Y 7Y 1.93% Exome Asset Management LLC 1.63% Logos Global Management LP 3Y 1.52% Kynam Capital Management, LP 3Y 1.46% ORBIMED ADVISORS LLC 3Y 7Y 1.25% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.22%
← Back to Engineers Gate Manager LP Holdings